Advertisement

Bedford-based medical device maker Insulet Corp. has signed an exclusive distribution agreement with GlaxoSmithKline Inc. in Canada. The deal relates to Insulet’s OmniPod Insulin Management System, a tubing-free insulin pump designed for continuous insulin delivery.

The agreement calls for GSK to gain exclusive marketing, promotion, advertising, distribution and sales rights for the OmniPod in Canada.

SOURCE

Advertisement
Advertisement